These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33093196)

  • 1. Visualization of the HIV-1 Env glycan shield across scales.
    Berndsen ZT; Chakraborty S; Wang X; Cottrell CA; Torres JL; Diedrich JK; López CA; Yates JR; van Gils MJ; Paulson JC; Gnanakaran S; Ward AB
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28014-28025. PubMed ID: 33093196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
    Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW
    J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth.
    Li Y; Bai H; Sanders-Buell E; Dussupt V; Townsley S; Donofrio G; Bose M; O'Sullivan AM; Kibuuka H; Maganga L; Nitayaphan S; Kosgei J; Pitisuttithum P; Rerks-Ngarm S; Eller LA; Michael NL; Robb ML; Ake J; Vasan S; Tovanabutra S; Krebs SJ; Rolland M
    J Virol; 2021 Aug; 95(17):e0079721. PubMed ID: 34160251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.
    Kong L; Torrents de la Peña A; Deller MC; Garces F; Sliepen K; Hua Y; Stanfield RL; Sanders RW; Wilson IA
    Acta Crystallogr D Biol Crystallogr; 2015 Oct; 71(Pt 10):2099-108. PubMed ID: 26457433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
    Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.
    Behrens AJ; Kumar A; Medina-Ramirez M; Cupo A; Marshall K; Cruz Portillo VM; Harvey DJ; Ozorowski G; Zitzmann N; Wilson IA; Ward AB; Struwe WB; Moore JP; Sanders RW; Crispin M
    J Proteome Res; 2018 Mar; 17(3):987-999. PubMed ID: 29420040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
    Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
    J Virol; 2017 May; 91(9):. PubMed ID: 28202756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.
    Schoofs T; Barnes CO; Suh-Toma N; Golijanin J; Schommers P; Gruell H; West AP; Bach F; Lee YE; Nogueira L; Georgiev IS; Bailer RT; Czartoski J; Mascola JR; Seaman MS; McElrath MJ; Doria-Rose NA; Klein F; Nussenzweig MC; Bjorkman PJ
    Immunity; 2019 Jun; 50(6):1513-1529.e9. PubMed ID: 31126879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational Heterogeneity of the HIV Envelope Glycan Shield.
    Yang M; Huang J; Simon R; Wang LX; MacKerell AD
    Sci Rep; 2017 Jun; 7(1):4435. PubMed ID: 28667249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.
    Zhou T; Doria-Rose NA; Cheng C; Stewart-Jones GBE; Chuang GY; Chambers M; Druz A; Geng H; McKee K; Kwon YD; O'Dell S; Sastry M; Schmidt SD; Xu K; Chen L; Chen RE; Louder MK; Pancera M; Wanninger TG; Zhang B; Zheng A; Farney SK; Foulds KE; Georgiev IS; Joyce MG; Lemmin T; Narpala S; Rawi R; Soto C; Todd JP; Shen CH; Tsybovsky Y; Yang Y; Zhao P; Haynes BF; Stamatatos L; Tiemeyer M; Wells L; Scorpio DG; Shapiro L; McDermott AB; Mascola JR; Kwong PD
    Cell Rep; 2017 Apr; 19(4):719-732. PubMed ID: 28445724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles.
    Hargett AA; Wei Q; Knoppova B; Hall S; Huang ZQ; Prakash A; Green TJ; Moldoveanu Z; Raska M; Novak J; Renfrow MB
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.
    Dubrovskaya V; Guenaga J; de Val N; Wilson R; Feng Y; Movsesyan A; Karlsson Hedestam GB; Ward AB; Wyatt RT
    PLoS Pathog; 2017 Sep; 13(9):e1006614. PubMed ID: 28902916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.
    Ahmed S; Shrivastava T; Kumar R; Kumar M; Banerjee M; Kumar N; Bansal M; Das S; Samal S
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129733. PubMed ID: 32949621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.
    Stewart-Jones GB; Soto C; Lemmin T; Chuang GY; Druz A; Kong R; Thomas PV; Wagh K; Zhou T; Behrens AJ; Bylund T; Choi CW; Davison JR; Georgiev IS; Joyce MG; Kwon YD; Pancera M; Taft J; Yang Y; Zhang B; Shivatare SS; Shivatare VS; Lee CC; Wu CY; Bewley CA; Burton DR; Koff WC; Connors M; Crispin M; Baxa U; Korber BT; Wong CH; Mascola JR; Kwong PD
    Cell; 2016 May; 165(4):813-26. PubMed ID: 27114034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.
    Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ
    J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer.
    Gristick HB; Wang H; Bjorkman PJ
    Acta Crystallogr D Struct Biol; 2017 Oct; 73(Pt 10):822-828. PubMed ID: 28994411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions.
    Seabright GE; Cottrell CA; van Gils MJ; D'addabbo A; Harvey DJ; Behrens AJ; Allen JD; Watanabe Y; Scaringi N; Polveroni TM; Maker A; Vasiljevic S; de Val N; Sanders RW; Ward AB; Crispin M
    Structure; 2020 Aug; 28(8):897-909.e6. PubMed ID: 32433992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
    J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.